Drug Development in Pre-Clinical Research

Before testing a drug in people, researchers must determine whether it's the potential to cause serious harm, also called toxicity. the 2 sorts of preclinical research are: In Vitro, In Vivo. Usually, preclinical studies aren't very large. However, these studies must provide detailed information on dosing and toxicity levels. After preclinical testing, researchers review their findings and choose whether the drug should be tested in people.

 

    Related Conference of Drug Development in Pre-Clinical Research

    April 14-15, 2025

    37th Nano Congress for Future Advancements

    Paris, France
    May 21-22, 2025

    5th World Congress on Nanotechnology and Advanced Materials

    Paris, France
    May 22-23, 2025

    33rd International Conference on Nanomedicine and Nanomaterials

    Toronto, Canada
    May 26-27, 2025

    5th International Conference on Nano Chemistry & Nano Medicine

    Rome, Italy
    June 16-17, 2025

    42nd Global Nanotechnology Congress

    Amsterdam, Netherlands
    June 24-25, 2025

    28th World Nanotechnology Congress

    Paris, France
    August 18-19, 2025

    37th International Conference and Expo on Nanosciences and Nanotechnology

    Valencia, Spain
    September 22-23, 2025

    35th World Nano Conference

    Dubai, UAE
    October 21-22, 2025

    42nd Global Summit on Nanoscience and Technology

    London, UK

    Drug Development in Pre-Clinical Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in